N-(2-(4-(2,2-dimethylpropionyloxy)phenylsulfonylamino)benzoyl)aminoacetic acid,
ONO 5046,
ONO-5046,
Ono-EI-600,
sivelestat,
Sivelestat,
127373-66-4,
Ono-5046,
ONO5046,
2-[[2-[[4-(2,2-dimethylpropanoyloxy)phenyl]sulfonylamino]benzoyl]amino]acetic acid,
Sivelestat (ONO-5046),
UNII-DWI62G0P59,
Ono 5046,
Elastase Inhibitor IV,
LY544349,
C20H22N2O7S,
Sivelestat sodium,
EI546,
N-(2-(4-(2,2-Dimethylpropionyloxy)phenylsulfonylamino)benzoyl)aminoacetic acid,
EI 546,
ONO-5046.Na,
CHEMBL76688,
LY 544349,
DWI62G0P59,
Glycine, N-(2-(((4-(2,2-dimethyl-1-oxopropoxy)phenyl)sulfonyl)amino)benzoyl)-,
N-(o-(p-Pivaloyloxybenzene)sulfonylaminobenzoyl)glycine,
2-(2-(4-(pivaloyloxy)phenylsulfonamido)benzamido)acetic acid,
o-(p-Hydroxybenzenesulfonamido)hippuric acid, pivalate (ester),
N-[2-(N'-(Carboxymethyl)-aminocarbonyl)-phenyl]-4-t-butylcarbonyloxybenzenesulfonamide,
Sivelestat [USAN],
Sivelestat [USAN:INN],
Ono-EI-600,
Silvelestat,
sivelestate sodium,
Sivelestat (USAN/INN),
AC1L32LG,
US9073833, Sivelestat,
SCHEMBL123221,
GTPL6441,
DTXSID9048304,
CTK8F0808,
sivelestat(anhydrous, free acid),
CHEBI:135704,
BDBM166439,
BCP09708,
KS-000002IP,
BDBM50084637,
IN1349,
s8136,
ZINC21298097,
AKOS022176173,
CS-2919,
DB12863,
QC-5742,
NCGC00346934-01,
AN-32579,
HY-17443,
P528,
SC-92389,
AX8069005,
LS-172679,
RT-012672,
A14184,
D03788,
373S664,
J-005486,
2-[[2-[(4-pivaloyloxyphenyl)sulfonylamino]benzoyl]amino]acetic acid,
2,2-Dimethyl-propionic acid 4-[2-(carboxymethyl-carbamoyl)-phenylsulfamoyl]-phenyl ester,
2-[(2-{4-[(2,2-dimethylpropanoyl)oxy]benzenesulfonamido}phenyl)formamido]acetic acid,
2-[[2-[[4-(2,2-dimethylpropanoyloxy)phenyl]sulfonylamino]phenyl]carbonylamino]ethanoic acid,
N-(2-(((4-(2,2-Dimethyl-1-oxopropoxy)phenyl)sulfonyl)amino)benzoyl)glycine,
2,2-Dimethyl-propionic acid 4-[2-(carboxymethyl-carbamoyl)-phenylsulfamoyl]-phenyl ester(ONO-5046),
ONO-5046|||2-[[2-[[4-(2,2-Dimethylpropanoyloxy)phenyl]sulfonylamino]benzoyl]amino]acetic acid,
Propanoic acid, 2,2-dimethyl-, 4-[[[2-[[(carboxymethyl)amino]carbonyl]phenyl]amino]sulfonyl]phenyl ester,
Elaspol,
Adalimumab,
Humira,
sivelestat sodium hydrate,
D0FT4R,
C20-H22-N2-O7-S,
CID107706,
ACN-040076,
ACN-040209,
C069195,
331731-18-1,
N-[o-(p-pivaloyloxybenzene)sulfonylaminobenzoyl]glycine,
201677-61-4,
N-[2-[[[4-(2,2-Dimethyl-1-oxopropoxy)phenyl]sulfonyl]amino]benzoyl]glycine,
37697-64-6,